FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013111251> ?p ?o ?g. }

• W2013111251 endingPage "40993" @default.
• W2013111251 startingPage "40987" @default.
• W2013111251 abstract "ABCA1 is an ATP-binding cassette protein that transports cellular cholesterol and phospholipids onto high density lipoproteins (HDL) in plasma. Lack of ABCA1 in humans and mice causes abnormal lipidation and increased catabolism of HDL, resulting in very low plasma apoA-I, apoA-II, and HDL. Herein, we have used Abca1-/- mice to ask whether ABCA1 is involved in lipidation of HDL in the central nervous system (CNS). ApoE is the most abundant CNS apolipoprotein and is present in HDL-like lipoproteins in CSF. We found that Abca1-/- mice have greatly decreased apoE levels in both the cortex (80% reduction) and the CSF (98% reduction). CSF from Abca1-/- mice had significantly reduced cholesterol as well as small apoE-containing lipoproteins, suggesting abnormal lipidation of apoE. Astrocytes, the primary producer of CNS apoE, were cultured from Abca1+/+, +/-, and -/- mice, and nascent lipoprotein particles were collected. Abca1-/- astrocytes secreted lipoprotein particles that had markedly decreased cholesterol and apoE and had smaller apoE-containing particles than particles from Abca1+/+ astrocytes. These findings demonstrate that ABCA1 plays a critical role in CNS apoE metabolism. Since apoE isoforms and levels strongly influence Alzheimer's disease pathology and risk, these data suggest that ABCA1 may be a novel therapeutic target. ABCA1 is an ATP-binding cassette protein that transports cellular cholesterol and phospholipids onto high density lipoproteins (HDL) in plasma. Lack of ABCA1 in humans and mice causes abnormal lipidation and increased catabolism of HDL, resulting in very low plasma apoA-I, apoA-II, and HDL. Herein, we have used Abca1-/- mice to ask whether ABCA1 is involved in lipidation of HDL in the central nervous system (CNS). ApoE is the most abundant CNS apolipoprotein and is present in HDL-like lipoproteins in CSF. We found that Abca1-/- mice have greatly decreased apoE levels in both the cortex (80% reduction) and the CSF (98% reduction). CSF from Abca1-/- mice had significantly reduced cholesterol as well as small apoE-containing lipoproteins, suggesting abnormal lipidation of apoE. Astrocytes, the primary producer of CNS apoE, were cultured from Abca1+/+, +/-, and -/- mice, and nascent lipoprotein particles were collected. Abca1-/- astrocytes secreted lipoprotein particles that had markedly decreased cholesterol and apoE and had smaller apoE-containing particles than particles from Abca1+/+ astrocytes. These findings demonstrate that ABCA1 plays a critical role in CNS apoE metabolism. Since apoE isoforms and levels strongly influence Alzheimer's disease pathology and risk, these data suggest that ABCA1 may be a novel therapeutic target. ABCA1 is the founding member of the ATP-binding cassette (ABC) 1The abbreviations used are: ABC, ATP-binding cassette; Aβ, amyloid-β peptide; ACM, astrocyte conditioned medium; AFM, atomic force microscopy; AD, Alzheimer's disease; CAA, cerebral amyloid angiopathy; CNS, central nervous system; CSF, cerebrospinal fluid; HDL, high density lipoprotein; RT, reverse transcription; ELISA, enzyme-linked immunosorbent assay; PBS, phosphate-buffered saline; apoE, apolipoprotein E; bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxy-methyl)propane-1,3-diol. 1The abbreviations used are: ABC, ATP-binding cassette; Aβ, amyloid-β peptide; ACM, astrocyte conditioned medium; AFM, atomic force microscopy; AD, Alzheimer's disease; CAA, cerebral amyloid angiopathy; CNS, central nervous system; CSF, cerebrospinal fluid; HDL, high density lipoprotein; RT, reverse transcription; ELISA, enzyme-linked immunosorbent assay; PBS, phosphate-buffered saline; apoE, apolipoprotein E; bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxy-methyl)propane-1,3-diol. family of transporters, which is the largest group of transmembrane transporters with 48 known family members in humans (1Dean M. Rzhetsky A. Allikmets R. Genome Res. 2001; 11: 1156-1166Crossref PubMed Scopus (1456) Google Scholar). All ABC transporters share homology in their ATP-binding domain and use ATP to translocate a wide variety of substrates across extra- and intracellular membranes (2Higgins C.F. Res. Microbiol. 2001; 152: 205-210Crossref PubMed Scopus (464) Google Scholar). Defects in ABC transporters cause at least 14 known genetic diseases (3Klein I. Sarkadi B. Varadi A. Biochim. Biophys. Acta. 1999; 1461: 237-262Crossref PubMed Scopus (505) Google Scholar). ABCA1 transports cellular cholesterol and phospholipids from cells onto high density lipoproteins (HDL) in plasma (4Schmitz G. Langmann T. Curr. Opin. Lipidol. 2001; 12: 129-140Crossref PubMed Scopus (179) Google Scholar, 5Wang N. Tall A.R. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1178-1184Crossref PubMed Scopus (215) Google Scholar). In humans, loss-of-function mutations in ABCA1 cause Tangier's disease (6Brooks-Wilson A. Marcil M. Clee S.M. Zhang L.H. Roomp K. van Dam M. Yu L. Brewer C. Collins J.A. Molhuizen H.O. Loubser O. Ouelette B.F. Fichter K. Ashbourne-Excoffon K.J. Sensen C.W. Scherer S. Mott S. Denis M. Martindale D. Frohlich J. Morgan K. Koop B. Pimstone S. Kastelein J.J. Genest Jr., J. Hayden M.R. Nat. Genet. 1999; 22: 336-345Crossref PubMed Scopus (1481) Google Scholar, 7Remaley A.T. Rust S. Rosier M. Knapper C. Naudin L. Broccardo C. Peterson K.M. Koch C. Arnould I. Prades C. Duverger N. Funke H. Assman G. Dinger M. Dean M. Chimini G. Santamarina-Fojo S. Fredrickson D.S. Denefle P. Brewer Jr., H.B. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 12685-12690Crossref PubMed Scopus (226) Google Scholar, 8Bodzioch M. Orso E. Klucken J. Langmann T. Bottcher A. Diederich W. Drobnik W. Barlage S. Buchler C. Porsch-Ozcurumez M. Kaminski W.E. Hahmann H.W. Oette K. Rothe G. Aslanidis C. Lackner K.J. Schmitz G. Nat. Genet. 1999; 22: 347-351Crossref PubMed Scopus (1328) Google Scholar, 9Rust S. Rosier M. Funke H. Real J. Amoura Z. Piette J.C. Deleuze J.F. Brewer H.B. Duverger N. Denefle P. Assmann G. Nat. Genet. 1999; 22: 352-355Crossref PubMed Scopus (1249) Google Scholar), which is characterized by accumulation of cholesterol in lymphatic tissues and increased catabolism of abnormally lipidated HDL, resulting in very low levels of plasma HDL and HDL-associated apolipoproteins A-I (apoA-I) and A-II (apoA-II) (10Schaefer E.J. Anderson D.W. Zech L.A. Lindgren F.T. Bronzert T.B. Rubalcaba E.A. Brewer Jr., H.B. J. Lipid Res. 1981; 22: 217-228Abstract Full Text PDF PubMed Google Scholar, 11Schaefer E.J. Blum C.B. Levy R.I. Jenkins L.L. Alaupovic P. Foster D.M. Brewer Jr., H.B. N. Engl. J. Med. 1978; 299: 905-910Crossref PubMed Scopus (127) Google Scholar). ABCA1 knock-out mice (Abca1-/-) have been produced, and the mice have a similar phenotype as patients with Tangier's disease (12McNeish J. Aiello R.J. Guyot D. Turi T. Gabel C. Aldinger C. Hoppe K.L. Roach M.L. Royer L.J. de Wet J. Broccardo C. Chimini G. Francone O.L. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 4245-4250Crossref PubMed Scopus (475) Google Scholar). However, neither Tangier's disease patients nor Abca1-/- mice have been examined to determine whether ABCA1 plays a role in lipidation or metabolism of lipoproteins in the central nervous system (CNS). The most abundant apolipoprotein in the CNS is apolipoprotein E (apoE), which is produced within the CNS, primarily by astrocytes and to some extent microglia (13Linton M.F. Gish R. Hubl S.T. Butler E. Esquivel C. Bry W.I. Boyles J.K. Wardell M.R. Young S.G. J. Clin. Invest. 1991; 88: 270-281Crossref PubMed Scopus (278) Google Scholar, 14Boyles J.K. Pitas R.E. Wilson E. Mahley R.W. Taylor J.M. J. Clin. Invest. 1985; 76: 1501-1513Crossref PubMed Scopus (640) Google Scholar, 15Newman T.C. Dawson P.A. Rudel L.L. Williams D.L. J. Biol. Chem. 1985; 260: 2452-2457Abstract Full Text PDF PubMed Google Scholar, 16Pitas R.E. Boyles J.K. Lee S.H. Foss D. Mahley R.W. Biochim. Biophys. Acta. 1987; 917: 148-161Crossref PubMed Scopus (563) Google Scholar, 17Stone D.J. Rozovsky I. Morgan T.E. Anderson C.P. Hajian H. Finch C.E. Exp. Neurol. 1997; 143: 313-318Crossref PubMed Scopus (219) Google Scholar). ApoE is present in brain tissue and in the cerebrospinal fluid (CSF), where it is present in HDL-like particles (18Pitas R.E. Boyles J.K. Lee S.H. Hui D. Weisgraber K.H. J. Biol. Chem. 1987; 262: 14352-14360Abstract Full Text PDF PubMed Google Scholar, 19LaDu M.J. Gilligan S.M. Lukens J.R. Cabana V.G. Reardon C.A. Van Eldik L.J. Holtzman D.M. J. Neurochem. 1998; 70: 2070-2081Crossref PubMed Scopus (242) Google Scholar, 20Borghini I. Barja F. Pometta D. James R.W. Biochim. Biophys. Acta. 1995; 1255: 192-200Crossref PubMed Scopus (148) Google Scholar). By analyzing brain tissue, CSF, plasma, and primary astrocyte cultures from Abca1+/+, +/-, and -/- mice, we determined that deletion of ABCA1 markedly affects metabolism of apoE and cholesterol in the CNS and in nascent lipoprotein particles secreted by cultured astrocytes. These findings have implications for neurological diseases involving apoE, such as Alzheimer's disease. Animals and Tissue Preparation—Mice heterozygous for the Abca1-null allele on a DBA background were obtained from the Jackson Laboratory, Bar Harbor, ME (strain name: DBA/1-Abca1tm1Jdm). These mice have similar abnormalities to those found in humans with Tangier's disease, such as greatly reduced plasma HDL (12McNeish J. Aiello R.J. Guyot D. Turi T. Gabel C. Aldinger C. Hoppe K.L. Roach M.L. Royer L.J. de Wet J. Broccardo C. Chimini G. Francone O.L. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 4245-4250Crossref PubMed Scopus (475) Google Scholar). The heterozygous mice were bred to one another to generate littermates with all Abca1 genotypes: wild type (Abca1+/+), heterozygous (Abca1+/-), and knock-out (Abca1-/-). All animals used for in vivo experiments were between 10 and 14 weeks old. For fluid and tissue analysis, animals were anesthetized with pentobarbital, CSF was collected from the cisterna magna as described (21DeMattos R.B. Brendza R.P. Heuser J.E. Kierson M. Cirrito J.R. Fryer J. Sullivan P.M. Fagan A.M. Han X. Holtzman D.M. Neurochem. Int. 2001; 39: 415-425Crossref PubMed Scopus (130) Google Scholar), blood was collected by cardiac puncture, and animals were perfused with PBS-heparin (3 units/ml). Regional brain dissection was performed, and brain samples were frozen on dry ice. ApoE ELISA—A sandwich ELISA for mouse apoE was developed with a sensitivity of ∼1 ng/ml. 96-well plates were coated overnight with 0.5 μg/well of a mouse monoclonal antibody (WU E-4) raised against apoE (22Krul E.S. Tikkanen M.J. Schonfeld G. J. Lipid Res. 1988; 29: 1309-1325Abstract Full Text PDF PubMed Google Scholar), washed with PBS, blocked with 1% milk in PBS, and then washed again. Brain samples were sonicated in 0.05% Tween in PBS with 1× Complete protease inhibitor mixture (1× protease inhibitors) (Roche Applied Science), debris was pelleted by a 10,000 × g × 15 min spin, and the supernatant was diluted in 0.1% bovine serum albumin, 0.025% Tween in PBS. Conditioned medium, plasma, and CSF were diluted directly into 0.1% bovine serum albumin, 0.025% Tween in PBS. Standards were based on pooled plasma from C57/Bl6 mice containing 68 μg/ml apoE as reported previously (23Lusis A.J. Taylor B.A. Quon D. Zollman S. LeBoeuf R.C. J. Biol. Chem. 1987; 262: 7594-7604Abstract Full Text PDF PubMed Google Scholar). Following sample incubation, the plate was washed, and 3 μg/well of biotinylated goat anti-apoE was added. The antibody was from Calbiochem (catalog number 178479) and was biotinylated using a biotin-maleimide reagent (Vector Laboratories, Burlingame, CA). After incubation of the secondary antibody, the plate was washed, and poly-horseradish peroxidase streptavidin (Pierce) was added at 1:6000 and incubated. The plate was then washed, developed with tetramethylbenzidine (Sigma), and read at 650 nm with a Biotek 600 plate reader (Bio-Tek Instruments, Winooski, VT). Real-time RT-PCR for Mouse ApoE—Following the perfusion of the animals, samples of cortex were placed in an RNAlater (Ambion, Austin, TX) and stored at 4 °C. RNA was extracted using the RNeasy lipid tissue kit (Qiagen, Valencia, CA) with on-column DNase digestion. RNA was quantified with a Bio-Rad SmartSpec 3000 (Bio-Rad). The forward primer used for mouse apoE was 5′-CCGTGCTGTTGGTCACATTGCTGACAGGAT-3′, and the reverse primer was 5′-GTTCTTGTGTGACTTGGGAGCTCTGCAGCT-3′. The 18 S primer/probe reagent used for normalization of RNA levels was from ABI (Foster City, CA). Brilliant SYBR Green QRT-PCR master mix kit, 1-step (Stratagene, La Jolla, CA) was used for the reverse transcription (RT)-PCR reaction. Master mix and RT/RNase block mix were added to 1 μm forward and reverse primers and 1.5 μg/ml RNA. For both apoE and 18 S RT and PCR, the samples were cycled in an ABI Prism 7000 sequence detection system at the following temperatures: 1) 50 °C for 30 min; 2) 95 °C for 10 min; 3) 96 °C for 30 s.; 4) 54 °C for 1 min; 5) 72 °C for 30 min; 6) repeat steps 3–5 40 times. Standard curves of critical threshold versus log concentration were plotted with RNA from wild type mouse cortex, and relative transcript levels were calculated using the ABI software that accompanied the Prism 7000. ApoJ Western Blot—Samples of cortex were sonicated in 1× radioimmune precipitation buffer with 1× protease inhibitors. Radioimmune precipitation buffer-insoluble material was removed by spinning at 10,000 × g × 15 min. 25 μg of total protein/well was run on a 10% bis-Tris gel (Invitrogen) and transferred onto a nitrocellulose membrane. The blot was probed with a rabbit anti-apoJ antibody developed in our laboratory (24Han B.H. DeMattos R.B. Dugan L.L. Kim-Han J.S. Brendza R.P. Fryer J.D. Kierson M. Cirrito J. Quick K. Harmony J.A. Aronow B.J. Holtzman D.M. Nat. Med. 2001; 7: 338-343Crossref PubMed Scopus (173) Google Scholar), washed, and then probed with anti-rabbit IgG linked to horseradish peroxidase (Amersham Biosciences). Bands were visualized with enhanced chemiluminescence (Pierce) and imaged with a Kodak Image Station (Eastman Kodak Co.). Cholesterol and Phospholipid Analyses—Brain samples were prepared for cholesterol analysis by sonication in PBS. The homogenized whole brain suspension was then subjected to enzymatic analysis for total cholesterol using the Amplex Red cholesterol kit (Molecular Probes, Eugene, OR). Results using the homogenized brain suspension were identical to those using chloroform-extracted lipids from brain (data not shown). CSF and astrocyte conditioned medium were diluted in the reaction buffer and assayed. Free cholesterol was measured using the same kit but omitting the cholesterol esterase enzyme. Esterified cholesterol was calculated as total cholesterol minus free cholesterol. Quantification of phospholipids species was performed with electrospray ionization mass spectrometry as described previously (25Han X. Yang J. Cheng H. Ye H. Gross R.W. Anal. Biochem. 2004; 330: 317-331Crossref PubMed Scopus (176) Google Scholar). Histological Analysis—Tissue sections were cut in the coronal plane at 50 μm on a freezing sliding microtome and mounted on Superfrost Plus slides (Fisher). For oil red O staining of neutral fat, slides were dipped consecutively into 70% ethanol for 1 s and then immersed for 5 min in 1% oil red O (Sigma), 35% ethanol and then 50% acetone. Slides were then washed in water, counterstained for 2 min in Harris' hematoxylin (Sigma), and washed in water. The slides were dipped in ammonia water (0.05% ammonium hydroxide) until blue, washed again, and mounted. Staining with cresyl violet to nuclei and Luxol fast blue to identify myelin were performed as described previously (26Holtzman D.M. Li Y.W. DeArmond S.J. McKinley M.P. Gage F.H. Epstein C.J. Mobley W.C. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 1383-1387Crossref PubMed Scopus (52) Google Scholar, 27Duerstock B.S. J. Neurosci. Methods. 2004; 134: 101-107Crossref PubMed Scopus (7) Google Scholar). Non-denaturing Gradient Gel Electrophoresis—Samples of CSF and astrocyte conditioned medium (ACM) were mixed 1:1 with native sample buffer and electrophoresed on a 4–20% Tris glycine gel (Invitrogen). Proteins with known hydrated diameters were used as size standards (Amersham Biosciences, catalog number 17044501), and proteins were transferred to a nitrocellulose membrane. For apoE immunoblotting, the membrane was probed with a goat anti-mouse apoE antibody at 1:100 (M-20 from Santa Cruz Biotechnology, Santa Cruz, CA), washed, and probed with horse anti-goat IgG linked to horseradish peroxidase at 1:1000 (Vector Laboratories). For apoA-I immunoblotting, the membrane was probed with a rabbit anti-mouse apoA-I antibody at 1:500 (Biodesign, Saco, ME), washed, and probed with goat anti-rabbit IgG linked to horseradish peroxidase at 1:1000 (Bio-Rad). Bands were visualized with enhanced chemiluminescence (Sigma) and imaged with a Kodak Image Station (Kodak). Primary Astrocyte Cultures—Primary cultures of forebrain astrocytes (>95% pure) were prepared from individual neonatal (1–3-day-old) mice as described previously (28Rose K. Goldberg M.P. Choi D.W. Tyson C.A. Frazier J.M. In Vitro Biological Methods: Methods in Toxicology. 1A. Academic Press, San Diego1993: 46-60Google Scholar). Astrocytes were grown in Dulbecco's modified Eagle's medium:F-12 containing 10% fetal bovine serum, 10% heat-inactivated horse serum, 1 mm sodium pyruvate, 100 units/ml penicillin, 100 μg/ml streptomycin, 250 ng/ml Fungizone, and 10 ng/ml epidermal growth factor (Sigma). To obtain ACM, confluent astrocyte cultures were washed twice with sterile PBS. Serum-free medium was added (Dulbecco's modified Eagle's medium:F-12, 1% N2 supplement (Invitrogen), 1 mm sodium pyruvate, 100 units/ml penicillin, 100 μg/ml streptomycin, 250 ng/ml Fungizone), and cells were incubated for 3 days. Media were then collected and spun at 2,000 × g × 10 min to remove cellular debris. 0.1% sodium azide and 1× protease inhibitors were added, and the ACM was stored at 4 °C until analysis. Following harvesting of ACM, astrocytes were scraped from the flasks, washed with PBS, pelleted, and sonicated in PBS. Fractionation of ACM—ACM was concentrated 40-fold with a 10-kDa molecular mass cut-off spin concentrator (Millipore, Billerica, MA). 1 ml of concentrated ACM was subjected to gel filtration chromatography using a BioLogic system (Bio-Rad) with tandem Superose-6 HR 10/30 columns (Amersham Biosciences) in 0.15 NaCl, 0.001 EDTA, 0.02% sodium azide as described previously (29Fagan A.M. Younkin L.H. Morris J.C. Fryer J.D. Cole T.G. Younkin S.G. Holtzman D.M. Ann. Neurol. 2000; 48: 201-210Crossref PubMed Scopus (113) Google Scholar). Atomic Force Microscopy (AFM)—Fraction 37 from Abca1+/+ ACM and fraction 51 from Abca1-/- were stored at 4 °C until AFM analysis. Samples were analyzed by in situ AFM as described previously (30Legleiter J. DeMattos R.B. Holtzman D.M. Kowalewski T. Colloid Interf. Sci. 2004; (in press)Google Scholar). Plasma and CNS Apolipoprotein Levels in Abca1-/- Mice— Previous studies have shown a near absence of plasma HDL and apoA-I in Abca1-/- mice consistent with a role for ABCA1 in cellular cholesterol and phospholipid efflux onto plasma HDL (12McNeish J. Aiello R.J. Guyot D. Turi T. Gabel C. Aldinger C. Hoppe K.L. Roach M.L. Royer L.J. de Wet J. Broccardo C. Chimini G. Francone O.L. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 4245-4250Crossref PubMed Scopus (475) Google Scholar). As apoE is also a constituent of plasma HDL, we measured plasma apoE levels and found that they were decreased by 96 and 54% in Abca1-/- and Abca1+/- mice, respectively, as compared with wild type littermates (Fig. 1A). Unlike plasma, which contains a variety of lipoprotein classes and in which apoA-I is the major apoprotein constituent of HDL, in the CSF, there are only HDL-like lipoproteins and apoE is the most abundant apoprotein. Further, apoE in CSF is derived from the CNS, not the plasma (13Linton M.F. Gish R. Hubl S.T. Butler E. Esquivel C. Bry W.I. Boyles J.K. Wardell M.R. Young S.G. J. Clin. Invest. 1991; 88: 270-281Crossref PubMed Scopus (278) Google Scholar). To determine whether ABCA1 plays a role in CNS apoE metabolism, we measured apoE levels in the CSF and brain of ABCA1-deficient mice. Interestingly, apoE levels in CSF were reduced to a similar extent as in plasma, with Abca1-/- mice having 98% and Abca1+/- mice having 46% reductions in apoE levels relative to wild type littermates (Fig. 1B). In brain tissue, apoE levels in cortex were reduced by 80 and 13% in Abca1-/- and +/- mice, respectively, as compared with wild type littermates (Fig. 1C). Real-time RT-PCR of apoE mRNA was performed on cortex from Abca1+/+, +/-, and -/- mice to determine whether differences in apoE protein levels were related to gene expression. There were no differences in apoE mRNA levels between the three genotypes (Fig. 1D), suggesting that ABCA1 affects apoE levels post-transcriptionally in the CNS. The second most abundant apoprotein produced in the CNS is apolipoprotein J (clusterin), and it is present in HDL-like particles in the CSF (19LaDu M.J. Gilligan S.M. Lukens J.R. Cabana V.G. Reardon C.A. Van Eldik L.J. Holtzman D.M. J. Neurochem. 1998; 70: 2070-2081Crossref PubMed Scopus (242) Google Scholar). To determine whether ABCA1 plays a role in the metabolism of apoJ in a similar manner to apoE, we measured apoJ levels in plasma, CSF, and cortex and found no significant differences among the different Abca1 genotypes (Fig. 1E and data not shown). ApoA-I is a major component of plasma HDL that is synthesized primarily in the periphery and enters the CNS in small quantities in relation to its very high plasma concentration (14Boyles J.K. Pitas R.E. Wilson E. Mahley R.W. Taylor J.M. J. Clin. Invest. 1985; 76: 1501-1513Crossref PubMed Scopus (640) Google Scholar). Its levels were greatly decreased in both CSF and cortex of Abca1-/- mice (see Fig. 3B and also data not shown). Since apoA-I levels in the plasma of Abca1-/- mice are near zero (14Boyles J.K. Pitas R.E. Wilson E. Mahley R.W. Taylor J.M. J. Clin. Invest. 1985; 76: 1501-1513Crossref PubMed Scopus (640) Google Scholar) and CNS apoA-I is derived mostly from plasma, this was an expected result. Lipids in CSF and Cortex of Abca1-/- Mice—Since the major function of ABCA1 outside the CNS is transport of cholesterol and phospholipids onto HDL, we examined whether ABCA1 deficiency altered the levels of cholesterol and phospholipids within the CNS. We found that total cholesterol in CSF was reduced by 24% in Abca1-/- mice as compared with wild type littermates (Fig. 2A). This is likely because ABCA1 deficiency results in decreased levels of HDL, the lipoprotein class that normally carries some proportion of cholesterol in the CSF. In contrast to CSF, total cholesterol levels in brain tissue (cortex) were not significantly different between Abca1+/+, +/-, and -/- mice (Fig. 2B). Cholesterol esters in cortex represented less than 5% of the total cholesterol and were also not significantly different (data not shown). Anionic phospholipids, choline glycerophospholipids, sphingomyelins, and ethanolamine glycerophospholipids were measured in cortex by electrospray ionization mass spectrometry and did not vary significantly between Abca1-/- and +/+ mice (n = 5 in each group, data not shown). To determine whether there was any lipid buildup in brain, we stained 3-month-old Abca1-/- and +/+ brain sections with oil red O. There was no evidence of abnormal lipid deposition in the Abca1-/- mice (Fig. 2C). Standard histological staining methods including cresyl violet for nuclei and Luxol fast blue for myelin also revealed no abnormalities in the brains of Abca1-/- mice (data not shown). Lipoprotein Particles from CSF and Astrocyte Conditioned Media of Abca1-/- Mice—In addition to evaluating the effects of ABCA1 deficiency on the levels of lipids and apoE in the CNS in vivo, we studied apoE- and apoA-I-containing lipoproteins in CSF and nascent apoE-containing lipoproteins produced by astrocytes to examine how ABCA1 deficiency affected their properties. We determined the size distribution of apoE- and apoA-I-containing lipoproteins in mouse CSF by non-denaturing gradient gel electrophoresis. As we have described previously (21DeMattos R.B. Brendza R.P. Heuser J.E. Kierson M. Cirrito J.R. Fryer J. Sullivan P.M. Fagan A.M. Han X. Holtzman D.M. Neurochem. Int. 2001; 39: 415-425Crossref PubMed Scopus (130) Google Scholar), apoE in CSF of wild type mice was in HDL-like particles 10–17 nm in diameter with the most abundant sizes being between 13 and 16 nm (Fig. 3A). ApoE particles from Abca1+/- CSF were similar in size to wild type. However, in addition to apoE levels in CSF from Abca1-/- being markedly reduced, apoE was present within particles that had a size distribution that was different from wild type mice. In addition to having a population of particles between 13 and 16 nm in diameter, CSF from Abca1-/- mice also had a population of smaller apoE-containing particles that were 7–8 nm in diameter, suggesting that they were poorly lipidated. ApoA-I was also greatly reduced in CSF from Abca1-/- mice, and the small amount that was there was present in particles of ∼7.3 nm as compared with particles of 8–11 nm in CSF from Abca1+/+ mice (Fig. 3B). Because Abca1-/- mice have both very low CSF apoE levels and altered particle size distribution, this led us to investigate whether there was a primary alteration of nascently produced apoE-containing HDL from astrocytes, the cells that produce the majority of apoE in the CNS. We compared total cholesterol and apoE in ACM derived from primary astrocyte cultures from Abca1+/+, +/-, and -/- mice and found that total levels of apoE in ACM did not vary by Abca1 genotype (Fig. 3E). However, the levels of total cholesterol were significantly lower in Abca1-/- ACM (Fig. 3D). This suggests that apoE is secreted at normal levels by Abca1-/- astrocytes, but the apoE is not normally lipidated in the absence of ABCA1. To examine the extent of lipidation of apoE-containing particles, ACM was subjected to size analysis by non-denaturing gradient gel electrophoresis followed by Western blotting for apoE. This demonstrated apoE-containing lipoprotein populations of ∼12, 11, and 8 nm in ACM from Abca1+/+ mice but much smaller lipoproteins in ACM from Abca1-/- mice of ∼7.3 and <7 nm (Fig. 3C). These data suggested that apoE-containing particles from Abca1-/- ACM were likely very lipid-poor. To analyze the lipid composition of astrocyte-secreted lipoproteins, ACM was fractionated by size exclusion chromatography. ApoE ELISAs and cholesterol assays of the different fractions demonstrated that lipoproteins from Abca1-/- ACM contain less apoE, are smaller, and have markedly less cholesterol than Abca1+/+ ACM (Fig. 4, A and B). Lipoprotein-associated apoE was reduced in Abca1-/- ACM by 80% as compared with Abca1+/+ ACM. As expected, ∼75% of the apoE in the Abca1+/+ ACM was in fractions 31–41, corresponding to the HDL size range. However, ∼75% of the lipoprotein-associated apoE in the Abca1-/- ACM was in fractions 45–55, which corresponds to much smaller particles. These smaller lipoprotein particles derived from Abca1-/- astrocytes were very cholesterol-poor as compared with Abca1+/+ particles (0.69 μg of total cholesterol/μg of apoE for Abca1-/-versus 2.3 μg of total cholesterol/μg of apoE for Abca1+/+). To confirm the size and shape of the abnormal Abca1-/- particles, AFM was performed on the size exclusion chromatography fractions from Abca1+/+ and Abca1-/- ACM with the highest apoE levels. AFM is a tool of choice because it allows for characterization of the three-dimensional shape of nanoparticles under nearly physiological conditions. Its use to study lipoprotein particles and the protocols needed to obtain reliable volume measurements were recently described elsewhere (31Legleiter J. Czilli D.L. Gitter B. DeMattos R.B. Holtzman D.M. Kowalewski T. J. Mol. Biol. 2004; 335: 997-1006Crossref PubMed Scopus (85) Google Scholar). The AFM images obtained demonstrate that the most abundant apoE-containing particles in Abca1-/- ACM are significantly smaller than in Abca1+/+ ACM (Fig. 4C). In this study, we have analyzed brain tissue, CSF, plasma, and primary astrocyte cultures from Abca1+/+, +/-, and -/- mice to determine whether deletion of ABCA1 affects metabolism of apoE, cholesterol, and phospholipids in the CNS and in nascent lipoprotein particles secreted by astrocytes. We found that Abca1-/- mice have greatly decreased apoE levels in the plasma (96% reduction), CSF (98% reduction), and cortex (80% reduction) as compared with Abca1+/+ mice. The decreased apoE levels in plasma and brain that we observed are similar to those seen by others. 2Hirsch-Reinshagen, V., Zhou, S., Burgess, B. L., Bernier, L., McIsaac, S. A., Chan, J. Y., Tansley, G. H., Cohn, J. S., Hayden, M. R., and Wellington, C. L. (2004) J. Biol. Chem. 10.1074/jbc.M407962200. The decreased apoE levels in the CNS are not related to Apoe gene expression but likely result from increased catabolism of abnormally lipidated apoE-containing HDL lipoproteins produced in the CNS, as occurs with abnormally lipidated apoA-I and apoA-II that are secreted by the liver and are rapidly catabolized in the plasma of Tangier's disease patients (10Schaefer E.J. Anderson D.W. Zech L.A. Lindgren F.T. Bronzert T.B. Rubalcaba E.A. Brewer Jr., H.B. J. Lipid Res. 1981; 22: 217-228Abstract Full Text PDF PubMed Google Scholar, 11Schaefer E.J. Blum C.B. Levy R.I. Jenkins L.L. Alaupovic P. Foster D.M. Brewer Jr., H.B. N. Engl. J. Med. 1978; 299: 905-910Crossref PubMed Scopus (127) Google Scholar). Although the alterations in CNS apoE levels were profound, differences in total CNS lipids were more subtle and present only in CSF. Brain tissue from Abca1+/+, +/-, and -/- mice had no differences in free cholesterol, esterified cho" @default.
• W2013111251 created "2016-06-24" @default.
• W2013111251 creator A5003807075 @default.
• W2013111251 creator A5006211066 @default.
• W2013111251 creator A5024057589 @default.
• W2013111251 creator A5038875566 @default.
• W2013111251 creator A5076271299 @default.
• W2013111251 creator A5081494138 @default.
• W2013111251 creator A5088998527 @default.
• W2013111251 creator A5090408781 @default.
• W2013111251 date "2004-09-01" @default.
• W2013111251 modified "2023-10-15" @default.
• W2013111251 title "ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE" @default.
• W2013111251 cites W1487168219 @default.
• W2013111251 cites W1492043593 @default.
• W2013111251 cites W1537961425 @default.
• W2013111251 cites W1580177128 @default.
• W2013111251 cites W1591670239 @default.
• W2013111251 cites W1607399348 @default.
• W2013111251 cites W1860908381 @default.
• W2013111251 cites W1963021413 @default.
• W2013111251 cites W1968954730 @default.
• W2013111251 cites W1971849044 @default.
• W2013111251 cites W1973125013 @default.
• W2013111251 cites W1981554609 @default.
• W2013111251 cites W1992653391 @default.
• W2013111251 cites W2004324219 @default.
• W2013111251 cites W2015786699 @default.
• W2013111251 cites W2017404389 @default.
• W2013111251 cites W2017961719 @default.
• W2013111251 cites W2021181758 @default.
• W2013111251 cites W2021449355 @default.
• W2013111251 cites W2026859908 @default.
• W2013111251 cites W2028195118 @default.
• W2013111251 cites W2029380839 @default.
• W2013111251 cites W2033536663 @default.
• W2013111251 cites W2037103758 @default.
• W2013111251 cites W2050767064 @default.
• W2013111251 cites W2058059121 @default.
• W2013111251 cites W2065559557 @default.
• W2013111251 cites W2067064610 @default.
• W2013111251 cites W2087839268 @default.
• W2013111251 cites W2101985994 @default.
• W2013111251 cites W2112488622 @default.
• W2013111251 cites W2115309238 @default.
• W2013111251 cites W2118569739 @default.
• W2013111251 cites W2119556701 @default.
• W2013111251 cites W2120393086 @default.
• W2013111251 cites W2127932326 @default.
• W2013111251 cites W2128986402 @default.
• W2013111251 cites W2138974950 @default.
• W2013111251 cites W2139877281 @default.
• W2013111251 cites W2147018428 @default.
• W2013111251 cites W2147413218 @default.
• W2013111251 cites W2152192643 @default.
• W2013111251 cites W2162959198 @default.
• W2013111251 cites W2163481458 @default.
• W2013111251 cites W2168971821 @default.
• W2013111251 cites W2306393560 @default.
• W2013111251 cites W2328390592 @default.
• W2013111251 cites W4294747801 @default.
• W2013111251 doi "https://doi.org/10.1074/jbc.m407963200" @default.
• W2013111251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15269217" @default.
• W2013111251 hasPublicationYear "2004" @default.
• W2013111251 type Work @default.
• W2013111251 sameAs 2013111251 @default.
• W2013111251 citedByCount "381" @default.
• W2013111251 countsByYear W20131112512012 @default.
• W2013111251 countsByYear W20131112512013 @default.
• W2013111251 countsByYear W20131112512014 @default.
• W2013111251 countsByYear W20131112512015 @default.
• W2013111251 countsByYear W20131112512016 @default.
• W2013111251 countsByYear W20131112512017 @default.
• W2013111251 countsByYear W20131112512018 @default.
• W2013111251 countsByYear W20131112512019 @default.
• W2013111251 countsByYear W20131112512020 @default.
• W2013111251 countsByYear W20131112512021 @default.
• W2013111251 countsByYear W20131112512022 @default.
• W2013111251 countsByYear W20131112512023 @default.
• W2013111251 crossrefType "journal-article" @default.
• W2013111251 hasAuthorship W2013111251A5003807075 @default.
• W2013111251 hasAuthorship W2013111251A5006211066 @default.
• W2013111251 hasAuthorship W2013111251A5024057589 @default.
• W2013111251 hasAuthorship W2013111251A5038875566 @default.
• W2013111251 hasAuthorship W2013111251A5076271299 @default.
• W2013111251 hasAuthorship W2013111251A5081494138 @default.
• W2013111251 hasAuthorship W2013111251A5088998527 @default.
• W2013111251 hasAuthorship W2013111251A5090408781 @default.
• W2013111251 hasBestOaLocation W20131112511 @default.
• W2013111251 hasConcept C104317684 @default.
• W2013111251 hasConcept C126322002 @default.
• W2013111251 hasConcept C134018914 @default.
• W2013111251 hasConcept C149011108 @default.
• W2013111251 hasConcept C169760540 @default.
• W2013111251 hasConcept C185592680 @default.
• W2013111251 hasConcept C190283241 @default.
• W2013111251 hasConcept C193469717 @default.
• W2013111251 hasConcept C203522944 @default.

• next